Hepatic injury during ketoconazole therapy in patients with onychomycosis: A controlled cohort study

Hepatology

Volumn 25, Issue 1, 1997, Pages 103-107

  Chien, Rong Nan ^a   Yang, Lih Jen ^a   Lin, Paul Y ^a   Liaw, Yun Fan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; GRISEOFULVIN; KETOCONAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; INCIDENCE; LIVER BIOPSY; LIVER CELL DAMAGE; MAJOR CLINICAL STUDY; MALE; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031021381     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250119     Document Type: Article

References (33)

1. Hell RC, Brogden RN, Carmine A, Morley PA, Speight TM, Avery GS. Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drug 1982;23:1-36.
2. Heiberg JK, Svejgaard E. Toxic hepatitis during ketoconazole treatment. BMJ 1981;283:825-826.
3. Macnair AL, Gascoigne E, Heap J, Schuermans V, Symoens J. Hepatitis and ketoconazole therapy. BMJ 1981;283:1058.
4. Firebrace DAJ. Hepatitis and ketoconazole therapy. BMJ 1981;283:1058-1059.
5. Horsburgh CR, Kirkpatrick CH, Teutsch CB. Ketoconazole and the liver. Lancet 1982;1:860.
6. Tkach JR, Rinaldi MG. Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis. Cutis 1982;29:482-484.
7. Okumura H, Aramaki T, Satomura K, Iizuka K, Ohta M, Katsuta Y, Akaike M, et al. Severe hepatitis during ketoconazole therapy. Gastroenterologia Japonica 1983;18:142-147.
8. Pegram PS, Kerns FT, Wasilauskas BL, Hampton KD, Scharyj M, Burke JG. Successful ketoconazole treatment of protothecosis with ketoconazole-associated hepatotoxicity. Arch Intern Med 1983;143:1802-1805.
9. Rollman O, Loof L. Hepatic toxicity of ketoconazole. Br J Dermatol 1983; 143:376-378.
10. Duarte PA, Chow CC, Simmons F, Ruskin J. Fetal hepatitis associated with ketoconazole therapy. Arch Intern Med 1984;144:1069-1070.
11. Svedhem A. Toxic hepatitis following ketoconazole treatment. Scand J Infect Dis 1984;16:123-125.
12. Bercoff E, Bernuau J, Degott C, Kalis B, Lemaire A, Tilly H, Rueff B, et al. Ketoconazole-induced fulminant hepatitis. Gut 1985;26:636-638.
13. Svejgaad E, Ranek L. Hepatic dysfunction and ketoconazole therapy. Ann Intern Med 1982;96:788-789.
14. Petersen EA, Alling DUV, Kirkpatrick CH. Treatment of chronic cutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med 1980;93:791-795.
15. Janssen PAJ, Symoens JE. Hepatic reactions during ketoconazole treatment. Am J Med 1983;74:80-85.
16. Janssen PAJ, Cauwenbergh G, Symoens J. Hepatic reactions during ketoconazole treatment: a 1 year update. Beerse; Janssen Pharmaceutica, 1983.
17. Lewis JH, Zimmerman HJ, Benson GD, Ishak KG. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology 1984;86:503-513.
18. Stricker BHC, Blok APR, Bronkhorst FB, Van Parys GE, Desmet VJ. Ketoconazole associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol 1986;3:399-406.
19. Chang KY, Chu CM, Chen TJ, Liaw YF. Ketoconazole-induced hepatic injury: report of 4 cases. Chin J Gastroenterol 1993;10:157-160.
20. Strauss JS. Ketoconazole and the liver. J Am Acad Dermatol 1982;6:546-547.
21. Lake-Bakaar G, Scheur PJ, Sherlock S. Hepatic reactions associated with ketoconazole in the United Kingdom. BMJ 1987;14:419-422.
22. Dismukes WE, Stamm AM, Graybill JR, Craven PC, Stevens DA, Stiller RL, Sarosi GA, et al. Treatment of systemic mycosis with ketoconazole: emphasis on toxicity and clinical response in 52 patients. Ann Intern Med 1983;98:13-20.
23. Benson GD, Anderson PK, Burton C, Ishak KG. Prolonged jaundice following ketoconazole-induced hepatic injury. Dig Dis Sci 1988;33:240-246.
24. Knight TE, Shikuma CY, Knight J. Ketoconazole-induced fulminant hepatitis necessitating liver transplantation. J Am Acad Dermatol 1991;25: 398-400.
25. Van Parys G, Evenepoel C, Van Damme B, Desmet VJ. Ketoconazole-induced hepatitis: a case with a definite cause-effect relationship. Liver 1987;7:27-30.
26. Klausner MA. Ketoconazole and hepatitis. J Am Acad Dermatol 1992;26: 1028-1029.
27. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
28. Zimmerman HJ. Classification of hepatotoxins and mechanisms of toxicity. In: Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. New York: Appleton-Century-Crofts, 1978:91-121.
29. Maddrey WC, Boitnott JK. Drug-induced chronic liver disease. Gastroenterology 1977;72:1348-1353.
30. Liaw YF, Huang MJ, Fan KD, Li KL, Wu SS, Chen TJ. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism: a cohort study. Ann Intern Med 1993;118:424-428.
31. Pessayre D. Role of reactive metabolites in drug induced hepatitis. J Hepatol 1995;23(suppl 1):16-24.
32. Young EJ, Weingarten NM, Baughn RE, Duncan WC. Studies on the pathogenesis of the Jarisch-Herxheimer reaction: development of an animal model and evidence against a role for classical endotoxin. J Infect Dis 1982;146:606-615.
33. Harrington PT, Gutierrez JJ, Ramirez-Ronda CH, Quinones-Soto R, Bermudez RH, Chaffey J. Granulomatous hepatitis. Rev Infect Dis 1982;4: 638-655.